Knowledge and understanding don’t stop at borders. We're working with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.
We’re working with the youth sector to help give young people from disadvantaged backgrounds more opportunities to engage with and take part in science activities outside school.
We support researchers across the world to explore fundamental questions about health and disease.
Emerging science and technologies, such as human genome editing and gene drive, could provide new solutions to health problems.
Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.
We want to secure the investment in research promised by the UK government to overcome the biggest challenges in the world, such as climate change and epidemics.
We want researchers to work and train in environments where world-class research and translation can thrive. So we invest in the places where research happens.
Over the past 25 years, we’ve made a number of critical strategic investments. These multi-million pound, long-term investments in people, resources and technology have helped transform key areas of science.
Our Research Leadership Development Programme connected senior researchers with great leaders to help improve their skills.
The European General Data Protection Regulation was agreed in April 2016 and took effect from 25 May 2018.
Why funding research into the humanities and social sciences is important, and what we're doing.
The people, projects and places we support include everyone from small community groups and charities to Nobel Prize winners and national galleries.
Sharing your ideas with the public and getting new perspectives can enhance your research. We offer public engagement funding, advice and training opportunities for all Wellcome-funded researchers.
The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.
Almost every major breakthrough in human and veterinary medicine has depended on the use of animals to research, develop or test new therapies.
Our Institutional Strategic Support Fund (ISSF) enables universities in the UK and Ireland to invest in areas that are of mutual strategic importance to Wellcome and the individual institutions.
Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.
The European Union is revising regulations governing the manufacture and sale of medical devices.
The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.
Wellcome collects public views on topics such as science, health and medical research through our Monitor surveys.